[{"Assets_0_Q3_USD":672585000.0,"CommonStockSharesOutstanding_0_Q3_shares":52120422.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":42965000.0,"NetIncomeLoss_1_Q3_USD":13073000.0,"NetIncomeLoss_3_Q3_USD":44361000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":52071000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":51849000.0,"StockholdersEquity_0_Q3_USD":619916000.0,"EarningsPerShareBasic_1_Q3_USD":0.25,"EarningsPerShareBasic_3_Q3_USD":0.86,"Ticker":"NEOG","CIK":"711377","name":"NEOGEN CORP","OfficialName":"Neogen Corporation Common Stock","form":"10-Q","period":"20190228","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3158444013.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20190329"}]